Paper41576151
Molecular mechanism of ziresovir targeting the fusion glycoprotein of respiratory syncytial virus.
Yan M and 7 others. PLoS Pathog, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Molecular mechanism of ziresovir targeting the fusion glycoprotein of respiratory syncytial virus. Papers, record 41576151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41576151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Molecular mechanism of ziresovir targeting the fusion glycoprotein of respiratory syncytial virus.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Viral Fusion Proteins | Major topic |
| Antiviral Agents | Major topic |
| Respiratory Syncytial Virus Infections | Major topic |
| Respiratory Syncytial Virus, Human | Major topic |
| Humans | |
| Animals | |
| Cryoelectron Microscopy | |
| Drug Resistance, Viral |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11352592 | Stabilization of short collagen-like triple helices by protein engineering. | J Mol Biol | 2001 | https://conductscience.org/library/papers/11352592 | PubMed |
| 2 | 39325881 | Mutating a flexible region of the RSV F protein can stabilize the prefusion conformation. | Science | 2024 | https://conductscience.org/library/papers/39325881 | PubMed |
| 3 | 30452608 | Severe Morbidity and Mortality Associated With Respiratory Syncytial Virus Versus Influenza Infection in Hospitalized Older Adults. | Clin Infect Dis | 2019 | https://conductscience.org/library/papers/30452608 | PubMed |
| 4 | 10864656 | The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate. | J Virol | 2000 | https://conductscience.org/library/papers/10864656 | PubMed |
| 5 | 40667369 | Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction. | bioRxiv | 2025 | https://conductscience.org/library/papers/40667369 | PubMed |
| 6 | 24362685 | Structure and function of respiratory syncytial virus surface glycoproteins. | Curr Top Microbiol Immunol | 2013 | https://conductscience.org/library/papers/24362685 | PubMed |
| 7 | 37502622 | Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trial. | Influenza Other Respir Viruses | 2023 | https://conductscience.org/library/papers/37502622 | PubMed |
| 8 | 26666922 | GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/26666922 | PubMed |
| 9 | 40246359 | Efficacy and safety of ziresovir in hospitalised infants aged 6 months or younger with respiratory syncytial virus infection in China: findings from a phase 3 randomised trial with 24-month follow-up. | Lancet Child Adolesc Health | 2025 | https://conductscience.org/library/papers/40246359 | PubMed |
| 10 | 31868913 | Estimated Burden of Community-Onset Respiratory Syncytial Virus-Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014-15. | J Pediatric Infect Dis Soc | 2020 | https://conductscience.org/library/papers/31868913 | PubMed |
| 11 | 11493675 | Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11493675 | PubMed |
| 12 | 27659812 | Drug candidates and model systems in respiratory syncytial virus antiviral drug discovery. | Biochem Pharmacol | 2017 | https://conductscience.org/library/papers/27659812 | PubMed |
| 13 | 26641933 | Molecular mechanism of respiratory syncytial virus fusion inhibitors. | Nat Chem Biol | 2016 | https://conductscience.org/library/papers/26641933 | PubMed |
| 14 | 20098425 | Structural basis of respiratory syncytial virus neutralization by motavizumab. | Nat Struct Mol Biol | 2010 | https://conductscience.org/library/papers/20098425 | PubMed |
| 15 | 33656652 | The Future of Respiratory Syncytial Virus Disease Prevention and Treatment. | Infect Dis Ther | 2021 | https://conductscience.org/library/papers/33656652 | PubMed |
| 16 | 38332002 | Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor. | Nat Commun | 2024 | https://conductscience.org/library/papers/38332002 | PubMed |
| 17 | 31194544 | Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein Inhibitor. | J Med Chem | 2019 | https://conductscience.org/library/papers/31194544 | PubMed |
| 18 | 27210812 | Cyclopiazonic acid, an inhibitor of calcium-dependent ATPases with antiviral activity against human respiratory syncytial virus. | Antiviral Res | 2016 | https://conductscience.org/library/papers/27210812 | PubMed |
| 19 | 29035372 | MMseqs2 enables sensitive protein sequence searching for the analysis of massive data sets. | Nat Biotechnol | 2017 | https://conductscience.org/library/papers/29035372 | PubMed |
| 20 | 15264254 | UCSF Chimera--a visualization system for exploratory research and analysis. | J Comput Chem | 2004 | https://conductscience.org/library/papers/15264254 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CAV1 | 857 | PubTator's text mining | https://conductscience.org/library/genes/857 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41576151
GET https://conductscience.org/api/papers/v1/41576151/references?page=2